CN105833016A - Traditional Chinese medicine composition for treating ovarian cancer - Google Patents
Traditional Chinese medicine composition for treating ovarian cancer Download PDFInfo
- Publication number
- CN105833016A CN105833016A CN201610365040.5A CN201610365040A CN105833016A CN 105833016 A CN105833016 A CN 105833016A CN 201610365040 A CN201610365040 A CN 201610365040A CN 105833016 A CN105833016 A CN 105833016A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- herba
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating ovarian cancer. The traditional Chinese medicine composition is prepared by, by weight, 0.3-0.9 part of radix acanthopanacis senticosi, 3.6-5.8 parts of brucea javanica, 0.6-2.8 parts of radix ginseng rubra, 5.0-8.3 parts of radix astragali, 2.1-3.5 parts of myrrh, 6.3-9.0 parts of radix lithospermi, 0.5-2.8 parts of ganoderma lucidum, 0.4-3 parts of panax notoginseng, 2.1-5.6 parts of ramulus cinnamomi, 0.2-2.3 parts of agrimonia pilosa ledeb, 40-50 parts of Smilax nipponica Miq., 15-25 parts of Veronica peregrina L., 10-20 parts of Schisandra glaucescens Diels., 5-8 parts of semen cuscutae, 9-13 parts of folium ginkgo and 3.0-9.6 parts of Scrophulariaceae Striga masuria. The traditional Chinese medicine composition has beneficial effects of strengthening the body resistance and consolidating the basis, invigorating qi to nourish the blood, promoting blood circulation to remove blood stasis, clearing away heat and toxic materials and resisting cancer and is evident in effect, quick in action and capable of resisting the ovarian cancer by coordinating with other treatment manners.
Description
Technical field
The invention belongs to treat the field of Chinese medicines of tumor.
Background technology
Malignant tumor of ovary is one of common malignant tumor of female sex organ, and sickness rate is only second to cervical cancer
With carcinoma of uterine body and arrange residence the 3rd.But ovarian epithelium mortality of carcinoma accounts for the first place of all kinds of gynecological tumor, to woman
Schoolgirl's life causes serious threat.Now it is intended to treat the Chinese medicine aspect of ovarian tumor, there are some the most not
Foot: one is that therapeutic effect is the most obvious;Two is that the comparison that takes effect is slow.To such an extent as to many ovarian cancer patients or
Recurring after can not effectively suppressing tumor growth, or excision, patient and family members thereof are not satisfied to this.
For posed problems above, the present invention provides a kind of Chinese medicine treating ovarian cancer, and it can solve the problem that in the past
In treatment of ovarian cancer, effect is obvious not, and the problem that the comparison that takes effect is slow is effective, instant effect, has effect
Significantly, the advantage of quick result.
Summary of the invention
Present invention aim to address the problem proposed in background technology.
In order to reach object above, the technical solution used in the present invention is as follows:
A kind of Chinese medicine composition treating ovarian cancer, is characterized in that: it is to make with the component of following weight ratio
, its component proportioning is:
Radix Et Caulis Acanthopanacis Senticosi 0.3-0.9 part, Fructus Bruceae 3.6-5.8 part, Radix Ginseng Rubra 0.6-2.8 part, Radix Astragali 5.0-8.3
Part, Myrrha 2.1-3.5 part, Radix Arnebiae (Radix Lithospermi) 6.3-9.0 part, Ganoderma 0.5-2.8 part, Radix Notoginseng 0.4-3 part, Ramulus Cinnamomi
2.1-5.6 part, Herba Agrimoniae 0.2-2.3 part, Rhizoma Smilacis nipponicae 40-50 part, Herba Veronicae peregrinae 15-25 part, flower blood
Rattan 10-20 part, Semen Cuscutae 5-8 part, Folium Ginkgo 9-13 part;Big Herba Lobeliae Chinensis 3.0-9.6 part, Fructus Broussonetiae 30-40
Part, fruit 10-16 part, Herba Silybi mariani fly Ji 0.8-7.6 part, Rhizoma Polygonati Cirrhifolii 17-35 part, Cornu Cervi Degelatinatum 4-15
Part, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 2-9 part, Radix Rhodiolae Yunnanensis 5-15 part, Herba Sedi 25-30 part, grand calyx angelica root 10-20 part,
Rhizoma Atractylodis Macrocephalae 4-15 part, Fructus Akebiae 3.2-6.8 part, Radix Aucklandiae 5.6-12 part, Radix Rehmanniae 9-12 part, Fructus Arctii 10-19
Part, Fructus Forsythiae 15-33 part.
The present invention compared with prior art, provides the benefit that: can solve the problem that effect during conventional treatment of ovarian cancer
Obvious not, the problem that the comparison that takes effect is slow, it is accordingly required in particular to it is noted that through practical proof many times,
Only when Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, the proportioning of Schisandra glaucescens Diels. are 0.3-0.9:3.6-5.8:10-20 when, association
Best with synergistic effect, the Chinese medicine composition of this treatment ovarian cancer is notable to treatment ovarian cancer effect, takes effect relatively
Hurry up.
Detailed description of the invention
The following is the specific embodiment of the present invention, technical scheme is described further, but
Embodiments of the present invention are not limited to these embodiments.
Embodiment 1, take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.6 part, Fructus Bruceae 4.3 parts, Radix Ginseng Rubra 2.0 parts, the Radix Astragali 6.3 parts, Myrrha 2.8
Part, Radix Arnebiae (Radix Lithospermi) 7.5 parts, Ganoderma 1.5 parts, Radix Notoginseng 2 parts, Ramulus Cinnamomi 2.9 parts, Herba Agrimoniae 1.8 parts,
Rhizoma Smilacis nipponicae 45 parts, Herba Veronicae peregrinae 20 parts, Schisandra glaucescens Diels. 15 parts, Semen Cuscutae 6 parts, Folium Ginkgo
10 parts, big Herba Lobeliae Chinensis 5.8 parts, Fructus Broussonetiae 33 parts, fruit 12 parts, Herba Silybi mariani 4.9 parts, old
Tiger Rhizoma Zingiberis Recens 22 parts, Cornu Cervi Degelatinatum 12 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 7.5 parts, Radix Rhodiolae Yunnanensis 11 parts, Herba Sedi 26 parts, grand
Calyx angelica root 18 parts, the Rhizoma Atractylodis Macrocephalae 9 parts, Fructus Akebiae 5.0 parts, the Radix Aucklandiae 8 parts, 10 parts of the Radix Rehmanniae, Fructus Arctii
17 parts, Fructus Forsythiae 22 parts.
(1) by above-mentioned weight ratio, Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, Ganoderma, Radix Notoginseng, Ramulus Cinnamomi, Herba Agrimoniae part, horse hair are stretched
Muscle, Herba Veronicae peregrinae, Schisandra glaucescens Diels., Fructus Broussonetiae, fruit, Herba Silybi mariani, Rhizoma Polygonati Cirrhifolii, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw., Radix Rhodiolae Yunnanensis,
Herba Sedi, Fructus Akebiae, the Radix Aucklandiae, clean roguing, dry, be ground into granule;
(2) take above-mentioned granule and add 3-8 times amount 42%-75% alcohol reflux 2-5 time, 1.0-2.5h/ time,
Alcohol extract;
(3) by above-mentioned weight ratio, by Radix Ginseng Rubra, the Radix Astragali, Myrrha, Radix Arnebiae (Radix Lithospermi), Semen Cuscutae, Folium Ginkgo, big Herba Lobeliae Chinensis,
Cornu Cervi Degelatinatum, grand calyx angelica root, the Rhizoma Atractylodis Macrocephalae, the Radix Rehmanniae, Fructus Arctii, Fructus Forsythiae are ground into fine powder respectively, with above-mentioned alcohol extract
It is sufficiently mixed, stirs, obtain medicine liquid mixture;
(4) above-mentioned medicine liquid mixture is added 1.5-2 times of water, soak 2-2.5h, be placed in multi-functional extraction in filling and decoct
2 times: add up the water of medical material 4-6 times amount for the first time, decocting 2h, take decocting liquid, filter, second time adds up medicine
The water of 8-10 times amount, decocts 2.5h, takes twice decocting liquid and merges, filters, and when being concentrated into 90 DEG C, relative density is
The concentrated solution of 1.38, sets to 0 concentrated solution-5 DEG C of deepfreeze 48h, obtains semi-finished product;
(5) again by the 4th step obtain described semi-finished product carry out successively filtration treatment, concentration, embedding process,
Sterilization treatment, obtains every milliliter of Chinese medicine composition oral liquid finished product containing 2.5g crude drug amount.
Embodiment 2, take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.4 part, Fructus Bruceae 3.8 parts, Radix Ginseng Rubra 1.0 parts, the Radix Astragali 5.3 parts, Myrrha 2.8 parts,
Radix Arnebiae (Radix Lithospermi) 6.5 parts, Ganoderma 0.8 part, Radix Notoginseng 0.5 part, Ramulus Cinnamomi 2.3 parts, Herba Agrimoniae 0.5 part, horse
Tail stretch 41 parts of muscle, Herba Veronicae peregrinae 16 parts, Schisandra glaucescens Diels. 11 parts, Semen Cuscutae 5.5 parts, Folium Ginkgo 10 parts,
Big Herba Lobeliae Chinensis 3.3 parts, Fructus Broussonetiae 32 parts, fruit 12 parts, Herba Silybi mariani 0.9 part, Rhizoma Polygonati Cirrhifolii 18
Part, Cornu Cervi Degelatinatum 6 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 2.5 parts, Radix Rhodiolae Yunnanensis 6.3 parts, Herba Sedi 26 parts, grand calyx Radix Angelicae Sinensis
Root 13 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, Fructus Akebiae 3.6 parts, the Radix Aucklandiae 5.8 parts, 10.5 parts of the Radix Rehmanniae, Fructus Arctii 12
Part, Fructus Forsythiae 17 parts.
By above-mentioned same method, make every milliliter of crude drug amount Chinese medicine composition oral liquid Han 2.5g.
Embodiment 3, take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.8 part, Fructus Bruceae 5.6 parts, Radix Ginseng Rubra 2.5 parts, the Radix Astragali 8.1 parts, Myrrha 3.3
Part, Radix Arnebiae (Radix Lithospermi) 8 parts, Ganoderma 2.5 parts, Radix Notoginseng 2.8 parts, Ramulus Cinnamomi 5.3 parts, Herba Agrimoniae 2.2 parts,
Rhizoma Smilacis nipponicae 49 parts, Herba Veronicae peregrinae 24 parts, Schisandra glaucescens Diels. 19 parts, Semen Cuscutae 7 parts, Folium Ginkgo 12 parts,
Big Herba Lobeliae Chinensis 9.3 parts, Fructus Broussonetiae 38.5 parts, fruit 10-16 part, Herba Silybi mariani 7.3 parts, tiger
Rhizoma Zingiberis Recens 32 parts, Cornu Cervi Degelatinatum 13 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 8 parts, Radix Rhodiolae Yunnanensis 14 parts, Herba Sedi 25-30 part, grand
Calyx angelica root 19 parts, the Rhizoma Atractylodis Macrocephalae 13.8 parts, Fructus Akebiae 6.3 parts, the Radix Aucklandiae 11.3 parts, 10.9 parts of the Radix Rehmanniae,
Fructus Arctii 18 parts, Fructus Forsythiae 31.8 parts.
By above-mentioned same method, make every milliliter of crude drug amount Chinese medicine composition oral liquid Han 2.5g.
Embodiment 4:
Take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 1.2 parts, Fructus Bruceae 2.6 parts, Radix Ginseng Rubra 2.5 parts, the Radix Astragali 8.1 parts, Myrrha 3.3
Part, Radix Arnebiae (Radix Lithospermi) 8 parts, Ganoderma 2.5 parts, Radix Notoginseng 2.8 parts, Ramulus Cinnamomi 5.3 parts, Herba Agrimoniae 2.2 parts,
Rhizoma Smilacis nipponicae 49 parts, Herba Veronicae peregrinae 24 parts, Schisandra glaucescens Diels. 8 parts, Semen Cuscutae 7 parts, Folium Ginkgo 12 parts,
Big Herba Lobeliae Chinensis 9.3 parts, Fructus Broussonetiae 38.5 parts, fruit 10-16 part, Herba Silybi mariani 7.3 parts, tiger
Rhizoma Zingiberis Recens 32 parts, Cornu Cervi Degelatinatum 13 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 8 parts, Radix Rhodiolae Yunnanensis 14 parts, Herba Sedi 25-30 part, grand
Calyx angelica root 19 parts, the Rhizoma Atractylodis Macrocephalae 13.8 parts, Fructus Akebiae 6.3 parts, the Radix Aucklandiae 11.3 parts, 10.9 parts of the Radix Rehmanniae,
Fructus Arctii 18 parts, Fructus Forsythiae 31.8 parts.
Illustrate: Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, Schisandra glaucescens Diels. proportioning not within the scope of described in claims.
Embodiment 5:
Take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.1 part, Fructus Bruceae 8 parts, Radix Ginseng Rubra 2.5 parts, the Radix Astragali 8.1 parts, Myrrha 3.3 parts,
Radix Arnebiae (Radix Lithospermi) 8 parts, Ganoderma 2.5 parts, Radix Notoginseng 2.8 parts, Ramulus Cinnamomi 5.3 parts, Herba Agrimoniae 2.2 parts, horse
Tail stretches 49 parts of muscle, Herba Veronicae peregrinae 24 parts, Schisandra glaucescens Diels. 3 parts, Semen Cuscutae 7 parts, Folium Ginkgo 12 parts, big
Herba Lobeliae Chinensis 9.3 parts, Fructus Broussonetiae 38.5 parts, fruit 10-16 part, Herba Silybi mariani 7.3 parts, Rhizoma Polygonati Cirrhifolii
32 parts, Cornu Cervi Degelatinatum 13 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 8 parts, Radix Rhodiolae Yunnanensis 14 parts, Herba Sedi 25-30 part, grand calyx
Angelica root 19 parts, the Rhizoma Atractylodis Macrocephalae 13.8 parts, Fructus Akebiae 6.3 parts, the Radix Aucklandiae 11.3 parts, 10.9 parts of the Radix Rehmanniae,
Fructus Arctii 18 parts, Fructus Forsythiae 31.8 parts.
Illustrate: Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, Schisandra glaucescens Diels. proportioning not within the scope of described in claims.
Clinical data:
The present invention is as a example by traditional Chinese medical science ovarian cancer, through 50 example clinical observations.Select tcm diagnosis ovarian cancer for mark
Accurate: limb is soft weak, lower abdominal distention pain, and CT is shown in ovary region tumors.As above symptom, can make a definite diagnosis.?
Making a definite diagnosis the object of observation, without other serious disease, the age is 31 years old-62 years old, 52.6 years old mean age.
Efficacy determination:
1, effective: body constitution strengthens, limbs are strong, and abdominal discomfort disappears, and ovarian tumor tumor body reduces, other portion
Position has no nascent tumor.
2, effective: body constitution strengthens, and ovarian tumor has no increase, and other position has no nascent tumor.
3, invalid: symptom is unchanged, ovarian tumor tumor body increases, or nascent tumor occurs in other position.
During clinical experiment, withdraw other medicines and health nutrient.Take Chinese medicine oral liquid of the present invention, observe 3
Individual month, be a course for the treatment of.Instructions of taking: three times a day, each 10ml, one after each meal, after 1 month
Symptom i.e. has alleviation, and after taking 3 months, symptom has clear improvement.
Take the medicinal liquid of embodiment 1 preparation: in 50 people of clinical experiment, effective 20 people, effective 29 people,
Invalid 1 people, total effective rate 98.0%.
Take the medicinal liquid of embodiment 2 preparation: in 50 people of clinical experiment, effective 20 people, effective 28 people,
Invalid 2 people, total effective rate 96.0%.
Take the medicinal liquid of embodiment 3 preparation: in 50 people of clinical experiment, effective 22 people, effective 27 people,
Invalid 1 people, total effective rate 98.0%.
Take the medicinal liquid of embodiment 4 preparation: in 50 people of clinical experiment, effective 2 people, effective 8 people,
Invalid 40 people, total effective rate 20.0%.
Take the medicinal liquid of embodiment 5 preparation: in 50 people of clinical experiment, effective 1 people, effective 9 people,
Invalid 40 people, total effective rate 20.0%.
Owing to embodiment 4 and embodiment 5 do not install the requirement proportioning preparation of the present invention, experiment effect is very
Difference, also illustrate that the medicine of the present invention is only when Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, the joining of Schisandra glaucescens Diels. to a certain extent
Than for the when of 0.3-0.9:3.6-5.8:10-20, cooperative synergism effect is just most preferably over the course for the treatment of.
Claims (1)
1. treat a Chinese medicine composition for ovarian cancer, it is characterized in that: it is to make with the component of following weight ratio
, its component proportioning is:
Radix Et Caulis Acanthopanacis Senticosi 0.3-0.9 part, Fructus Bruceae 3.6-5.8 part, Radix Ginseng Rubra 0.6-2.8 part, Radix Astragali 5.0-8.3
Part, Myrrha 2.1-3.5 part, Radix Arnebiae (Radix Lithospermi) 6.3-9.0 part, Ganoderma 0.5-2.8 part, Radix Notoginseng 0.4-3 part, Ramulus Cinnamomi
2.1-5.6 part, Herba Agrimoniae 0.2-2.3 part, Rhizoma Smilacis nipponicae 40-50 part, Herba Veronicae peregrinae 15-25 part, flower blood
Rattan 10-20 part, Semen Cuscutae 5-8 part, Folium Ginkgo 9-13 part;Big Herba Lobeliae Chinensis 3.0-9.6 part, Fructus Broussonetiae 30-40
Part, fruit 10-16 part, Herba Silybi mariani 0.8-7.6 part, Rhizoma Polygonati Cirrhifolii 17-35 part, Cornu Cervi Degelatinatum 4-15 part,
Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 2-9 part, Radix Rhodiolae Yunnanensis 5-15 part, Herba Sedi 25-30 part, grand calyx angelica root 10-20 part, the Rhizoma Atractylodis Macrocephalae
4-15 part, Fructus Akebiae 3.2-6.8 part, Radix Aucklandiae 5.6-12 part, Radix Rehmanniae 9-12 part, Fructus Arctii 10-19 part,
Fructus Forsythiae Fructus Forsythiae 15-33 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610365040.5A CN105833016A (en) | 2016-05-26 | 2016-05-26 | Traditional Chinese medicine composition for treating ovarian cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610365040.5A CN105833016A (en) | 2016-05-26 | 2016-05-26 | Traditional Chinese medicine composition for treating ovarian cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105833016A true CN105833016A (en) | 2016-08-10 |
Family
ID=56594710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610365040.5A Pending CN105833016A (en) | 2016-05-26 | 2016-05-26 | Traditional Chinese medicine composition for treating ovarian cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105833016A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106267029A (en) * | 2016-10-12 | 2017-01-04 | 南宁多灵生物科技有限公司 | A kind of Chinese medicine composition treating ovarian cancer |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1361697A (en) * | 1999-08-12 | 2002-07-31 | 研究及应用科学协会股份有限公司 | Use of ginkgo extract |
CN102198226A (en) * | 2011-06-09 | 2011-09-28 | 彭道生 | Chinese herbal medicine composition for treating cancer |
CN102335374A (en) * | 2011-10-09 | 2012-02-01 | 许俊斋 | Medicine special for treating lung cancer |
CN102423369A (en) * | 2011-12-29 | 2012-04-25 | 许从玉 | Chinese medicinal composition for preventing or treating ovarian cancer |
CN103705897A (en) * | 2014-01-03 | 2014-04-09 | 陈延玲 | Cancer pain-relieving plaster |
CN104800565A (en) * | 2015-04-14 | 2015-07-29 | 王先宝 | Traditional Chinese medicine for treating esophagus cancer and preparation method |
CN105311468A (en) * | 2015-11-16 | 2016-02-10 | 张秀贞 | Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof |
-
2016
- 2016-05-26 CN CN201610365040.5A patent/CN105833016A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1361697A (en) * | 1999-08-12 | 2002-07-31 | 研究及应用科学协会股份有限公司 | Use of ginkgo extract |
CN102198226A (en) * | 2011-06-09 | 2011-09-28 | 彭道生 | Chinese herbal medicine composition for treating cancer |
CN102335374A (en) * | 2011-10-09 | 2012-02-01 | 许俊斋 | Medicine special for treating lung cancer |
CN102423369A (en) * | 2011-12-29 | 2012-04-25 | 许从玉 | Chinese medicinal composition for preventing or treating ovarian cancer |
CN103705897A (en) * | 2014-01-03 | 2014-04-09 | 陈延玲 | Cancer pain-relieving plaster |
CN104800565A (en) * | 2015-04-14 | 2015-07-29 | 王先宝 | Traditional Chinese medicine for treating esophagus cancer and preparation method |
CN105311468A (en) * | 2015-11-16 | 2016-02-10 | 张秀贞 | Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106267029A (en) * | 2016-10-12 | 2017-01-04 | 南宁多灵生物科技有限公司 | A kind of Chinese medicine composition treating ovarian cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN105477183A (en) | Health care wine and preparing method thereof | |
CN101537146B (en) | Chinese medicine for treating carcinoma of colon | |
CN104173565B (en) | A kind of Chinese medicine composition treating menoxenia | |
CN101530508B (en) | Traditional Chinese medicine for treating ovarian cancer | |
CN101390993B (en) | Traditional Chinese medicine for treating diabetic foot | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN1246031C (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
CN105833016A (en) | Traditional Chinese medicine composition for treating ovarian cancer | |
CN101518611B (en) | Traditional Chinese medicine for treating bone tumor | |
CN101530490B (en) | Traditional Chinese medicine for treating bladder cancer | |
CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
CN101554426B (en) | Traditional Chinese medicine for treating diabetic obstipation | |
CN101985027A (en) | Chinese herbal medicine for treating liver cirrhosis | |
CN101537125B (en) | Chinese medicine for treating uterine cancer | |
CN101537061B (en) | Chinese medicine for treating liver cancer | |
CN100502938C (en) | Chinese medicine for gynecological infertility | |
CN101513516B (en) | Drug for treating annexitis | |
CN101390985B (en) | Traditional Chinese medicine for treating diabetes acral necrosis | |
CN106266929A (en) | A kind of blood circulation promoting and blood stasis dispelling life-prolonging pill and preparation method thereof | |
CN104225311A (en) | Neurasthenia heart and spleen tonifying medicament and preparation method | |
CN104383211A (en) | Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy | |
CN104248689A (en) | Traditional Chinese medicine for treating female sexual hypoactivity | |
CN104800703A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
CN104758702A (en) | Liver soothing and bladder relieving agent for treating gallstone and preparation method of agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160810 |
|
WD01 | Invention patent application deemed withdrawn after publication |